Larsen TS - Search Results

1

[Status and perspectives on chronic myeloproliferative neoplasm treatment].

Ocias LF, Holmström MO, Riley CH, Andersen CL, Rønnov-Jessen D, Starklint J, Frederiksen M, Steffensen MS, Bjerrum OW, Farmer S, Mourits-Andersen T, Hasselbalch HC, Larsen TS. Ocias LF, et al. Among authors: larsen ts. Ugeskr Laeger. 2015 May 4;177(19):V12140652. Ugeskr Laeger. 2015. PMID: 25967090 Free article. Review. Danish.

2

V617F mutation in JAK2 is associated with poorer survival in idiopathic myelofibrosis.

Campbell PJ, Griesshammer M, Döhner K, Döhner H, Kusec R, Hasselbalch HC, Larsen TS, Pallisgaard N, Giraudier S, Le Bousse-Kerdilès MC, Desterke C, Guerton B, Dupriez B, Bordessoule D, Fenaux P, Kiladjian JJ, Viallard JF, Brière J, Harrison CN, Green AR, Reilly JT. Campbell PJ, et al. Among authors: larsen ts. Blood. 2006 Mar 1;107(5):2098-100. doi: 10.1182/blood-2005-08-3395. Epub 2005 Nov 17. Blood. 2006. PMID: 16293597 Free article.

3

[New molecular markers within the chronic myeloproliferative disorders. I: the PRV-1 gene].

Larsen TS, Pallisgaard N, Christensen JH, Gram-Hansen P, Kerndrup GB, Møller MB, Hasselbalch HC. Larsen TS, et al. Ugeskr Laeger. 2006 Sep 25;168(39):3295-9. Ugeskr Laeger. 2006. PMID: 17032591 Review. Danish.

4

[New molecular markers within the chronic myeloproliferative disorders. II: the JAK2 mutation].

Larsen TS, Pallisgaard N, Christensen JH, Gram-Hansen P, Kerndrup GB, Møller MB, Hasselbalch HC. Larsen TS, et al. Ugeskr Laeger. 2006 Sep 25;168(39):3299-303. Ugeskr Laeger. 2006. PMID: 17032592 Review. Danish.

5

A der(18)t(9;18)(p13;p11) and a der(9;18)(p10;q10) in polycythemia vera associated with a hyperproliferative phenotype in transformation to postpolycythemic myelofibrosis.

Larsen TS, Hasselbalch HC, Pallisgaard N, Kerndrup GB. Larsen TS, et al. Cancer Genet Cytogenet. 2007 Jan 15;172(2):107-12. doi: 10.1016/j.cancergencyto.2006.09.015. Cancer Genet Cytogenet. 2007. PMID: 17213018

6

The JAK2 V617F mutation involves B- and T-lymphocyte lineages in a subgroup of patients with Philadelphia-chromosome negative chronic myeloproliferative disorders.

Larsen TS, Christensen JH, Hasselbalch HC, Pallisgaard N. Larsen TS, et al. Br J Haematol. 2007 Mar;136(5):745-51. doi: 10.1111/j.1365-2141.2007.06497.x. Br J Haematol. 2007. PMID: 17313377 Free article.

7

Quantitative assessment of the JAK2 V617F allele burden: equivalent levels in peripheral blood and bone marrow.

Larsen TS, Pallisgaard N, Møller MB, Hasselbalch HC. Larsen TS, et al. Leukemia. 2008 Jan;22(1):194-5. doi: 10.1038/sj.leu.2404861. Epub 2007 Jul 12. Leukemia. 2008. PMID: 17625603 No abstract available.

8

The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis--impact on disease phenotype.

Larsen TS, Pallisgaard N, Møller MB, Hasselbalch HC. Larsen TS, et al. Eur J Haematol. 2007 Dec;79(6):508-15. doi: 10.1111/j.1600-0609.2007.00960.x. Epub 2007 Oct 23. Eur J Haematol. 2007. PMID: 17961178

9

[Tyrosine kinase inhibitors in the treatment of polycythemia vera and related conditions. Danish Society of Hematology].

Larsen TS, Hasselbalch HC; Dansk Haematologisk Selskab. Larsen TS, et al. Ugeskr Laeger. 2008 Mar 17;170(12):1031. Ugeskr Laeger. 2008. PMID: 18397649 Danish. No abstract available.

10

Sustained major molecular response on interferon alpha-2b in two patients with polycythemia vera.

Larsen TS, Bjerrum OW, Pallisgaard N, Andersen MT, Møller MB, Hasselbalch HC. Larsen TS, et al. Ann Hematol. 2008 Oct;87(10):847-50. doi: 10.1007/s00277-008-0498-4. Epub 2008 May 15. Ann Hematol. 2008. PMID: 18481066

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

193 results

Search Page